21st Austria weekly - ATX TR at 7557.38 Do &Co best performing and with new all-time-highs 17/02/2024 [pic1]A good week for which gained 1 42 percent to 7.557 3 points. But in times when comparable indices are hitting all time highs a year date minus of still 0 77 is not so exciting. Impressive Do&Co however stock the also highs. News came from Strabag Telekom Verbund Kapsch TrafficCom Marinomed CA Immo Vienna
21st Austria weekly - Marinomed CA Immo Vienna Airport RBI 14/02/2024 [pic1]Marinomed: Marinomed Biotech AG generated revenues of € 9.2 m in 2023 the majority which was again recognized through sale Carragelose products. As expected revenue decreased by 18.6 % compared to previous year 2022: 11.3 m. This is primarily related lower order volumes following high stock levels partners. Cash and cash equivalents 2.6 8.2 Compared level at end Q3 2023 € 2.8 m this position remained nearly stable as a result stricter management resumption convertible note funding program with Nice & Green. Marinomed’s top priorities 2024 are partnering lead Marinosolv products maximizing value asset well obtaining market approval for US.Marinomed Biotech:
21st Austria weekly - Marinomed CA Immo Vienna Airport RBI 14/02/2024 [pic1]Marinomed: Marinomed Biotech AG generated revenues of € 9.2 m in 2023 the majority which was again recognized through sale Carragelose products. As expected revenue decreased by 18.6 % compared to previous year 2022: 11.3 m. This is primarily related lower order volumes following high stock levels partners. Cash and cash equivalents 2.6 8.2 Compared level at end Q3 2023 € 2.8 m this position remained nearly stable as a result stricter management resumption convertible note funding program with Nice & Green. Marinomed’s top priorities 2024 are partnering lead Marinosolv products maximizing value asset well obtaining market approval for US.Marinomed Biotech:
EQS-News: Marinomed Biotech AG / Key word: Preliminary Results
Marinomed Biotech AG announces preliminary revenue for 2023
14.02.2024 / 07:45 CET/CEST
The issuer is.